Short Sleep Duration and Sleep Disturbance as a Trigger of Migraine
Short Sleep Duration and Sleep Disturbance as a Trigger of Migraine
批准号:
9145810
负责人:
Suzanne Bertisch
金额:
$17.35万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-20 至 2018-03-31
关键词:
AccountingAddressAlcoholsAmericanBehaviorCase SeriesCholineChronicChronic stressClinicalClinical ManagementCohort StudiesDataDevelopmentDimensionsDiseaseEmployeeEpidemiologic MethodsEpidemiologyEtiologyFoundationsFrequenciesGeneticGoalsHealthHistamineHourHygieneIncidenceIndividualInternetInterventionInvestigationIsraelKnowledgeLeftLinkMeasuresMediatingMedicalMedical centerMedicineMigraineMorbidity - disease rateNeurologicNeuronsNeurotransmittersNorepinephrineOutcomePainParticipantPathogenesisPathway interactionsPatient Self-ReportPatientsPatternPersonsPharmacotherapyPhysical FunctionPhysiologicalPopulationPreventionPrevention strategyProcessPublic HealthRecurrenceReportingResearchResearch SupportRiskRoleSecureSelf-control as a personality traitSleepSleep FragmentationsSleep disturbancesStimulusStressSymptomsSyndromeSystemTestingTimeUnited StatesWakefulnessWorkWristactigraphyawakebaseburden of illnesscausal modelclinical practicecognitive functioncostdesigndiarieseffective therapyexperiencehypocretininnovationinsightintense painmedical schoolsneuronal excitabilityneurovascularnovelpreventprogramstargeted treatmenttreatment strategytrendtriptans
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): More than 10% of Americans suffer from migraine, a poorly understood chronic neurological syndrome, characterized by unpredictable, recurrent attacks marked by intense pain, altered cognitive functioning, and physiologic disturbances. Migraine ranks among the most disabling medical conditions, and costs $12 billion/year in lost employee time in the United States. Despite the high burden of migraine and the availability of targeted pharmacotherapy (i.e., triptans), effective treatment and prevention remains elusive for many patients. Disrupted sleep, including "too short sleep," is identified by >50% of migraine sufferers as a trigger of migraine, and clinical practice dictates sleep hygiene to migraines. Yet,
few studies have examined the precise temporal relationships of specific sleep attributes that may provoke migraine, leaving a gap in our knowledge as to how nightly patterns of sleep, including short sleep duration and disturbed sleep, relate to next-day risk of migraine. Congruently, there are few data exploring the reciprocal pathway whereby migraine impacts sleep. We propose a novel cohort study to quantify the bidirectional, temporal relationship between a single night of short sleep duration and migraine onset. We will also explore the independent, temporal association between fragmented sleep (low sleep efficiency) and migraine. Lastly, we will explore if shifts in sleep midpoint and short periods of cumulative sleep
loss (2 nights of short sleep) predict migraine onset. Addressing this knowledge gap has critical implications for the etiology, prevention and treatment of migraine. We prospectively collect daily objective (via actigraphy) for six weeks in 100 patients with migraine. Using a state-of-the-art epidemiologic approach-the self-controlled case series design, we will achieve two specific aims: (1) to quantify the independent contribution of sleep duration as a temporal precedent of migraine; (2) to identify the temporality and impact of other objective measures of disturbed sleep, including sleep fragmentation and shifts in sleep midpoint, as triggers of migraine. The proposed study will definitively establish the temporal relationship between short sleep duration and risk of migraine attacks. Refining our understanding of the causal role of sleep duration and sleep disruption in migraine pathogenesis would justify further investigations of novel, targeted interventions that modify specific aspects of sleep for persons with migraine. Our work will also generate insights for future research disentangling the neurobiologic processes linking sleep with migraine. We anticipate this proposed work would contribute substantively to our understanding of the bidirectional relationship between sleep and migraine and support innovative and aggressive management of sleep disruption in patients with migraine, thereby mitigating the enormous burden of this chronic neurovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A hybrid effectiveness-implementation trial evaluating behavioral treatments for insomnia for socioeconomic disadvantaged adults in primary care
-
批准号:10507411
-
项目类别:
-
资助金额:$56.3万
-
财政年份:2022
-
负责人:Suzanne Bertisch
-
依托单位:
Physiology of Mind-Body Therapies: Meditative Breathing and Autonomic Adaptations
-
批准号:7995242
-
项目类别:
-
资助金额:$13.01万
-
财政年份:2009
-
负责人:Suzanne Bertisch
-
依托单位:
Physiology of Mind-Body Therapies: Meditative Breathing and Autonomic Adaptations
-
批准号:8310768
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2009
-
负责人:Suzanne Bertisch
-
依托单位:
Physiology of Mind-Body Therapies: Meditative Breathing and Autonomic Adaptations
-
批准号:7849090
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2009
-
负责人:Suzanne Bertisch
-
依托单位:
Physiology of Mind-Body Therapies: Meditative Breathing and Autonomic Adaptations
-
批准号:8119782
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2009
-
负责人:Suzanne Bertisch
-
依托单位:
Physiology of Mind-Body Therapies: Meditative Breathing and Autonomic Adaptations
-
批准号:8526387
-
项目类别:
-
资助金额:$13.03万
-
财政年份:2009
-
负责人:Suzanne Bertisch
-
依托单位:
海外基金